Southwest Health Center | |
1400 East Side Rd, Platteville, Wisconsin 53818 | |
(608) 348-2331 | |
Name | Southwest Health Center |
---|---|
Type | Critical Access Hospital |
Location | 1400 East Side Rd, Platteville, Wisconsin |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 521354 |
NPI Number | 1831279793 |
Organization Name | SOUTHWEST HEALTH CENTER, INC |
Address | 1400 Eastside Rd, Platteville, WI 53818 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 608-348-2331 |
News Archive
Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials.
The risk for hospitalization doubles for kids with asthma who are exposed to secondhand smoke, according to a study led by Mayo Clinic Children's Research Center. "The results of this review serve as a reminder to parents of just how dangerous it is to expose their children to secondhand smoke," says Avni Joshi, M.D., senior author and pediatric allergist and immunologist at Mayo Clinic Children's Center.
A new set of strategies released today by the Commonwealth Fund Commission on a High Performance Health System could dramatically improve how the U.S. health care system serves vulnerable populations-those in the U.S. who are uninsured, low-income, or members of racial and ethnic minority groups.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Piperacillin and Tazobactam for Injection, the number one prescribed intravenous antibiotic in the U.S. APP will launch the product immediately.
AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company's transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials.
The risk for hospitalization doubles for kids with asthma who are exposed to secondhand smoke, according to a study led by Mayo Clinic Children's Research Center. "The results of this review serve as a reminder to parents of just how dangerous it is to expose their children to secondhand smoke," says Avni Joshi, M.D., senior author and pediatric allergist and immunologist at Mayo Clinic Children's Center.
A new set of strategies released today by the Commonwealth Fund Commission on a High Performance Health System could dramatically improve how the U.S. health care system serves vulnerable populations-those in the U.S. who are uninsured, low-income, or members of racial and ethnic minority groups.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Piperacillin and Tazobactam for Injection, the number one prescribed intravenous antibiotic in the U.S. APP will launch the product immediately.
AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company's transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.
› Verified 4 days ago
Southwest Health Center Critical Access Hospital Location: 1400 East Side Rd, Platteville, Wisconsin 53818 Phone: (608) 348-2331 |